Xingke Rong Medicine (06833.HK) proposes to appoint Bai Zhizhong as the Chief Independent Non-Executive Director.

Wisdom Finance and Economics APP news, Xingke Rong Pharmaceutical (06833.HK) announced that Ms. Jing Huan and Mr. Bai Zhizhong have been appointed as members of the Nomination Committee, effective from August 27, 2025; and proposed to appoint Mr. Bai Zhizhong as the company's Chief Independent Non-Executive Director, effective from August 27, 2025.